SHL Telemedicine signs a distribution agreement for the smartheart™ device with FUJIFILM Sonosite for the U.S., Japan and Germany.
Tel Aviv/Zurich, 7 May, 2015 – SHL Telemedicine Ltd. (SIX Swiss Exchange: SHLTN), a leading provider and developer of advanced personal telemedicine solutions, today announced it has signed an international distribution agreement for its innovative smartheart™ device with FUJIFILM SonoSite, Inc.
smartheart™ is the first and only personal mobile 12-lead ECG device on the market that enables the detection of heart attacks. FUJIFILM SonoSite will distribute the smartheart™ device to its professional healthcare customers in the US, Japan and Germany, using its point-of-care ultrasound solutions. With smartheart and a smartphone or tablet they can perform a full hospital grade ECG and send it to a clinic, a hospital or SHL’s telemedicine center for diagnosis.
For more information click here